Cognition Therapeutics to Present Analyses from Clinical Studies of CT1812 in Patients with Alzheimer’s Disease at AD/PD 2022 - read this article along with other careers information, tips and advice on BioSpace
HOUSTON, March 03, 2022 Salarius Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options, today announced. | March 3, 2022
/PRNewswire/ Caring Cross, a 501(c)(3) non-profit dedicated to accelerating the development of advanced medicines and enabling access to cures for all.
/PRNewswire/ Third Pole Therapeutics, a privately held company developing critical life-sustaining cardio-pulmonary therapies, announced today that it has.
/PRNewswire/ Third Pole Therapeutics, a privately held company developing critical life-sustaining cardio-pulmonary therapies, announced today that it has.